Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (939)	8/7/1998 1:43:00 AM
From: Ms. Forthright	Read Replies (1) \| Respond to of 1185

Wisee, To the best of my knowledge all of the analysts who have taken a look at Nortran place its value at about $4.00 with what they have now. It amazes me that people are willing to sell at $1.00. Most sells do seem small so perhaps these individuals haven't bothered to research the company. I agree it hurts now, but odds are very good that one of their compounds will be a blockbuster (particularly since the cough suppressant has already passed clinical trials). Best Regards, Ms. F